| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | 66.5 | ¤749,327 | US |
| JNJ | Johnson & Johnson | 61.8 | ¤379,413 | US |
| ABT | Abbott Laboratories | 65.2 | ¤232,443 | US |
| MRK | Merck & Co., Inc. | 71.3 | ¤210,977 | US |
| ISRG | Intuitive Surgical, Inc. | 67.2 | ¤188,546 | US |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| BMRN | BioMarin Pharmaceutical Inc. | 70.4 | ¤11,280 | US |
| MOH | Molina Healthcare, Inc. | 51.1 | ¤12,389 | US |
| UTHR | United Therapeutics Corporation | 71.5 | ¤13,539 | US |
| ALGN | Align Technology, Inc. | 52.8 | ¤14,822 | US |
| HOLX | Hologic, Inc. | 48.3 | ¤14,897 | US |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| AMGN | Amgen Inc. | 62.2 | 30 | US |
| LLY | Eli Lilly and Company | 66.5 | 25 | US |
| PFE | Pfizer Inc. | 54.4 | 23 | US |
| DGX | Quest Diagnostics Incorporated | 57.8 | 21 | US |
| ZTS | Zoetis, Inc. Class A | 59.3 | 21 | US |
| JNJ | Johnson & Johnson | 61.8 | 20 | US |
| TMO | Thermo Fisher Scientific Inc. | 49.0 | 20 | US |
| RMD | ResMed Inc. | 73.0 | 18 | US |
| UTHR | United Therapeutics Corporation | 71.5 | 17 | US |
| A | Agilent Technologies, Inc. | 50.9 | 15 | US |
| Average Market Cap | ¤99,780 |
| Median Market Cap | ¤35,272 |
| Avg. 3 Mo. Dollar Vol. | ¤509,546,714 |
| Avg. 3 Mo. Trading Vol. | 4,073,449 |
| Last Rebalance Date | 03/24/2025 |
| Companies Replaced | 20 |
| Biggest Sector Increase | Health Care |
| Biggest Sector Decrease | Health Care |
| Trailing P/E Ratio (12 Mo.) | 28.2 |
| Forward P/E Ratio (12 Mo.) | 19.1 |
| Price/Book Ratio | 3.9 |
| Avg. Revenue Chg. - 3 Yr | 16.1% |
| Avg. Op. Income Chg. - 3 Yr. | 21.5% |
| Avg. EPS Growth - 3 Yr. | 7.1% |
| Avg. EPS Growth - 1 Yr. | 10.7% |
| Avg. Operating Margin | 22.6% |
| Avg. LT Debt to Total Capital | 36.3% |
| Avg. Return on Equity | 18.9% |
| Dividend Yield | 0% |
| US Health Care Index | 57.78 |
| United States Of America | 93.33% |
| Switzerland | 3.33% |
| Ireland | 3.33% |
